IP Verse

Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases - EP3131582

The patent EP3131582 was granted to Vertex Pharmaceuticals Incorporated on May 23, 2018. The application was originally filed on Apr 14, 2015 under application number EP15721912A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3131582

VERTEX PHARMACEUTICALS INCORPORATED
Application Number
EP15721912A
Filing Date
Apr 14, 2015
Status
Granted And Under Opposition
Apr 20, 2018
Grant Date
May 23, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKFeb 22, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (39) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2003144257
DESCRIPTIONUS2004006237
DESCRIPTIONUS2004105820
DESCRIPTIONUS2005164973
DESCRIPTIONUS2006035943
DESCRIPTIONUS2006148863
DESCRIPTIONUS2006148864
DESCRIPTIONUS2009131492
DESCRIPTIONUS2013316981
DESCRIPTIONUS6992096
DESCRIPTIONUS7202262
DESCRIPTIONUS8247436
DESCRIPTIONWO0152902
DESCRIPTIONWO2004028480
DESCRIPTIONWO2004080972
DESCRIPTIONWO2004091502
DESCRIPTIONWO2004110352
DESCRIPTIONWO2004111014
DESCRIPTIONWO2005035514
DESCRIPTIONWO2005049018
DESCRIPTIONWO2005094374
DESCRIPTIONWO2005120497
DESCRIPTIONWO2006044456
DESCRIPTIONWO2006044502
DESCRIPTIONWO2006044503
DESCRIPTIONWO2006044505
DESCRIPTIONWO2006044682
DESCRIPTIONWO2006099256
DESCRIPTIONWO2006101740
DESCRIPTIONWO2006110483
DESCRIPTIONWO2006127588
DESCRIPTIONWO2007044560
DESCRIPTIONWO2011113894
INTERNATIONAL-SEARCH-REPORTWO2011119984
INTERNATIONAL-SEARCH-REPORTWO2013185112
INTERNATIONAL-SEARCH-REPORTWO2014014841
OPPOSITIONWO2011119984
OPPOSITIONWO2013185112
OPPOSITIONWO2014014841

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- chapter 115, chapter 115, Limmer D. ET AL, REMINGTON The Science and Practice of Pharmacy, (20000000), page 1970, XP055578003-
OPPOSITION- "Committee for Proprietary Medicinal Products (CPMP) Note for Guidance on Fixed Combination Medicinal Products", EMA, (19960417), pages 1 - 5, XP055577990-
OPPOSITION- "KALYDECO TM(IVACAFTOR) Tablets", KALYDECO TM label, (20120000), pages 1 - 13, XP055577989-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents